| Literature DB >> 35749373 |
Janine Sagaceta-Mejía1, Lizbeth Tolentino-Mayo1, Carlos Cruz-Casarrubias1, Claudia Nieto1, Simón Barquera1.
Abstract
One strategy for the prevention and treatment of non-communicable diseases (NCDs) is the implementation of the front-of-pack labeling (FoPL) in foods and beverages. In 2020, Mexico adopted the warning label system (WL) as a new public health policy, whose aim is to help consumers make healthier food choices. Previously, the Guideline Daily Amount (GDA) was the labelling used it. This paper aims to compare the understanding of two FoPL, the GDA and the WL, through the identification of unhealthy products in Mexicans with NCDs. We analyzed data from 14,880 Mexican adults older than 20 years old with NCDs (overweight-obesity (OW/O), self-reported diabetes mellitus 2 (DM2), or/and hypertension (HT), or/and dyslipidemia (Dys)). Participants were randomly assigned to one of two groups: the GDA labeling or WL. Each group had to respond to a survey and had to classify food products images as healthy or unhealthy according to the labelling system to which they were assigned. The correct classification was determined according to the criteria of Chile's labeling nutrient profile stage 3. To evaluate the correct classification in each one of the groups we evaluated the differences in proportions. Logistic regression models were used to assess the likelihood to correctly classify the product according to participants' number of diseases and WL information, taking GDA label as a reference. Participants who used the information contained in the GDA label misclassified food product labels in greater proportion (70%), mostly participants with three or more NCDs (participants with OW/O+ HT+ Dys, represent 42.3% of this group); compared with those who used WL (50%). The odds of correct classification of food products using WL image were two times greater compared to GDA image in participants with NCDs; being greater in participants with three or more NCDs. The study results highlight the usefulness of WL as it helps Mexicans with NCDs to classify unhealthy food products more adequately compared with GDA.Entities:
Mesh:
Year: 2022 PMID: 35749373 PMCID: PMC9231753 DOI: 10.1371/journal.pone.0269892
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Images used in questionnaires one (GDA) and two (WL) of two product labels used for the assessment of understanding and their corresponding classification.
GDA and WL images of two food products shown to the participants. *A food product is unhealthy when it contains excess of calories and/or critical nutrients. The reference cut-off points were based on Chile’s labelling nutrient profile stage 3 criteria.
Sociodemographic characteristics of the population by type of food labeling.
| Total population | GDA | WL | P-value | |
|---|---|---|---|---|
| n = 14,880 | n = 7,479 | n = 7,401 | ||
| % (95%CI) | % (95%CI) | % (95%CI) | ||
| Total | 50.5 (49.5;51.5) | 49.5 (48.5;50.5) | ||
|
| 0.911 | |||
| Women | 57.5 (56.4,58.7) | 57.1 (55.4,58.8) | 57.2 (55.5,59.0) | |
| Men | 42.5 (41.4,43.7) | 42.9 (41.2,44.7) | 42.8 (41.0,44.5) | |
|
| 0.701 | |||
| 20–29 | 24.8 (23.6,26.0) | 25.4 (23.8,27.0) | 24.2 (22.7,25.8) | |
| 30–39 | 20.9 (19.9,21.9) | 21.0 (19.7,22.4) | 20.7 (19.4,22.1) | |
| 40–49 | 21.0 (20.1,22.0) | 20.9 (19.5,22.3) | 21.2 (19.8,22.6) | |
| 50–59 | 15.95 15.0,16.9) | 15.5 (14.2,16.8) | 16.5 (15.2,17–8) | |
| ≥60 | 17.4 (16.4,18.4) | 17.3 (16.0,18.7) | 17.5 (16.2,18.8) | |
|
| 0.747 | |||
| ≤Elementary school | 28.5 (27.3,29.7) | 28.8 (27.3,30.3) | 28.2 (26.6,29.8) | |
| Middle school | 30.9 (29.7,32.2) | 30.5 (28.9,32.2) | 31.3 (29.7,32.3) | |
| ≥High school | 40.6 (39.2,42.0) | 40.7 (38.9,42.5) | 40.5 (38.6,42.4) | |
|
| 0.603 | |||
| South | 31.3 (28.9,33.8) | 31.9 (29.4,34.6) | 30.7 (28.1,33.4) | |
| North | 19.5 (17.8,21.2) | 19.2 (17.5,21.1) | 19.7 (17.9,21.6) | |
| Center | 35.8 (32.9,38.8) | 35.3 (32.5,38.3) | 36.2 (33.0,39.5) | |
| Mexico City | 13.5 (11.7,15.5) | 13.5 (11.6,15.8) | 13.4 (11.3,15.9) | |
|
| 0.440 | |||
| Rural | 25.6 (23.2,28.2) | 25.9 (23.4,28.6) | 25.3 (22.7,28.1) | |
| Urban | 74.4 (71.8,76.8) | 74.1 (71.4,76.6) | 74.7 (71.9,77.3) | |
|
| 0.039 | |||
| Low | 19.8 (18.1,21.7) | 20.2 (18.4,22.1) | 19.3 (17.3,21.6) | |
| Middle-low | 52.7 (50.6,54.9) | 52.3 (50.1,54.6) | 53.5 (50.8,56.1) | |
| Middle-high | 20.1 (18.6,21.7) | 19.4 (17.8,21.1) | 21.0 (19.0,23.1) | |
| High | 7.4 (6.5,8.4) | 8.1 (6.9,9.4) | 6.6 (5.7,7.8) | |
|
| 0.679 | |||
| 0 | 18.9 (17.9,19.9) | 18.6 (17.4,19.9) | 19.2 (17.9,20.5) | |
| 1 | 48.7 (47.5,50.0) | 49.1 (47.3,50.8) | 48.3 (46.6,50.0) | |
| 2 | 20.9 (19.9,21.9) | 21.2 (19.8,22.7) | 20.7 (19.3,22.1) | |
| ≥3 | 11.5 (10.7,12.4) | 11.2 (10.1,12.3) | 11.5 (10.7,12.4) |
Abbreviations: 95% CI, 95% Confidence Interval, GDA: Guideline Daily Amount, WL: Warning Label
P-value obtained from the test Χ2
Prevalence of number and type of non-communicable diseases in Mexican population.
| Condition | Percentage % (95% CI) |
|---|---|
| 0 | 18.9 (17.9,19.9) |
| 1 | 48.7 (47.5,50.0) |
| 2 | 20.9 (19.9,21.9) |
| ≥3 | 11.5 (10.7,12.4) |
| OW/O | 91.4 (90.3,92.5) |
| HT | 2.8 (2.3,3.4) |
| DM2 | 1.8 (1.4,2.3) |
| Dys | 4.0 (3.1,4.9) |
| OW/O+HT | 34.8 (32.1,37.6) |
| OW/O+DM2 | 12.3 (10.7,14.0) |
| OW/O+Dys | 47.3 (44.6,50.0) |
| HT+DM2 | 1.3 (0.9,2.1) |
| HT+Dys | 2.4 (1.7,3.5) |
| DM2+Dys | 1.9 (1.4,2.7) |
| OW/O+HT+Dys | 42.3 (38.5,46.1) |
| OW/O+HT+DM2 | 16.5 (14.1,19.1) |
| OW/O+DM2+Dys | 18.2 (15.7,21.0) |
| HT+DM2+Dys | 1.6 (0.9,2.6) |
| OW/O+HT+Dys+DM2 | 21.5 (18.8,24.4) |
Abbreviations: 95% CI: 95% Confidence Interval, NCDs: Non-communicable diseases, OW/O: Overweight/Obesity; HT: Hypertension; DM2: Diabetes Mellitus 2; Dys: Dyslipidemia
Proportions of correct classification of two product labels according to the number of diseases and type of non-communicable diseases.
| Type of FoPL | P-value | ||
|---|---|---|---|
| GDA | WL | ||
| % (95%CI) | % (95%CI) | ||
|
| |||
|
| |||
| 0 | 25.6 (21.5,30.1) | 45.6 (40.6,50.6) | <0.001 |
| 1 | 27.2 (24.5,30.1) | 51.9 (48.6,55.2) | <0.001 |
| 2 | 25.5 (21.7,29.6) | 48.8 (44.3,53.3) | <0.001 |
| ≥3 | 22.6 (17.4,28.8) | 46.3 (40.7,51.9) | <0.001 |
|
| |||
| OW/O | 27.8 (24.5,30.8) | 52.4 (49.0,55.7) | <0.001 |
| OW/O+HT | 26.9 (21.9,32.6) | 49.7 (43.4,56.1) | <0.001 |
| OW/O+HT+Dys | 21.9 (14.3,32.0) | 49.6 (40.3,58.9) | <0.001 |
|
| |||
|
| |||
| 0 | 36.2 (31.8,40.9) | 51.9 (47.0,56.7) | <0.001 |
| 1 | 39.5 (36.6,42.6) | 56.4 (53.1,59.7) | <0.001 |
| 2 | 33.0 (29.1,37.2) | 54.0 (49.7,58.3) | <0.001 |
| ≥3 | 29.7 (24.6,35.3) | 50.2 (44.7,55.7) | <0.001 |
|
| |||
| OW/O | 41.1 (38.0,44.3) | 57.2 (53.9,60.4) | <0.001 |
| OW/O+HT | 40.1 (34.3,46.2) | 57.0 (50.8,62.9) | <0.001 |
| OW/O+HT+Dys | 27.3 (20.3,35.7) | 53.6 (44.5,62.4) | <0.001 |
Abbreviations: 95% CI: 95% Confidence Interval, NCDs: Non-communicable diseases, OW/O: Overweight/Obesity; HT: Hypertension; DM2: Diabetes Mellitus 2; Dys: Dyslipidemia, GDA: Guide Daily Amount, WL: Warning Label
* GDA: n = 5,122, N expanded = 9,363,129; WL: n = 5,815, N expanded = 10,628,174
** GDA: n = 5,618, N expanded = 10,300,360; WL: n = 6,249, N expanded = 11,407,007
Odds ratio of correct classification of two product labels using WL over GDA by number of diseases.
| Product label 1 | Product label 2 | |
|---|---|---|
| OR (95% CI) | OR (95% CI) | |
|
| ||
| 0 | 2.79 | 2.18 |
| 1 | 2.75 | 2.01 |
| 2 | 2.55 | 2.26 |
| ≥3 | 2.88 | 2.26 |
Abbreviations: 95% CI: 95% Confidence Interval, OR odds ratio, WL Warning Label.
*** P-value<0.001
n = 14,880; N expanded = 25,650,088
ֆCoefficients, confidence intervals and p value correspond to the interaction among WL and number of diseases.
Logistic model adjusted by sex, age, education level, region, locality, and socioeconomic level.